-

07:49:46 AM

LIVE Real Time DVAX Stock Market News

DVAX - Dynavax Technologies Corp.

04/22/21 4:05 PM

Nasdaq : DVAX

Dynavax to Report First Quarter 2021 Financial Results and Host Conference Call on May 6, 2021

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, will report first quarter 2021 financial results on Thursday, May 6, 2021, after the U.S. financial markets

RHEA-AI

neutral

04/21/21 4:01 PM

Nasdaq : DVAX

Valneva Initiates Pivotal Phase 3 Clinical Trial for its Inactivated, COVID-19 Vaccine Candidate using Dynavax's CpG 1018(TM) Adjuvant

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced Valneva SE has initiated a pivotal Phase 3 clinical trial for its inactivated, COVID-19 vaccine

RHEA-AI

neutral

04/19/21 4:10 PM

Nasdaq : DVAX

Two HEPLISAV-B Abstracts Selected for Oral Presentation at the 2021 Annual Conference on Vaccinology Research (ACVR)

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that two HEPLISAV-B abstracts have been selected for oral presentation at the 2021 Annual

RHEA-AI

neutral

04/06/21 6:00 AM

Nasdaq : DVAX

Positive Phase 1/2 Results for Valneva's Inactivated COVID-19 Vaccine Candidate Using Dynavax's CpG 1018(TM) Adjuvant

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that Valneva SE reported positive initial results for Part A of the Phase 1/2 clinical trial of

RHEA-AI

neutral

04/02/21 4:05 PM

Nasdaq : DVAX

Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that it has granted nonstatutory stock options to purchase an aggregate of 142,000 shares of Dynavax common stock as inducements to six newly-hired employees in connection with

RHEA-AI

very positive

03/24/21 8:00 AM

Nasdaq : DVAX

Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing transformative biologics such as vaccines and therapeutics for the world's most debilitating diseases, and Dynavax Technologies

RHEA-AI

very positive

03/01/21 4:15 PM

Nasdaq : DVAX

Dynavax to Present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Ryan Spencer , Chief Executive Officer, will present at the H.C. Wainwright Virtual 2021 Global

RHEA-AI

neutral

03/01/21 4:14 PM

Nasdaq : DVAX

Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that in connection with the commencement of Ms. MacDonald's employment with the Company as Senior Vice President and Chief Financial Officer on March 1, 2021, the Company granted her a

RHEA-AI

very positive

02/25/21 4:02 PM

Nasdaq : DVAX

Dynavax Announces Fourth Quarter and Full Year 2020 Financial Results

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the fourth quarter and full year 2020."2020 was an important year for

RHEA-AI

neutral

02/19/21 12:20 PM

Nasdaq : DVAX

Dynavax Announces European Commission Marketing Authorization for HEPLISAV B(R), a 2 Dose Adult Hepatitis B Adjuvanted Vaccine

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that the European Commission (EC) has granted Marketing Authorization for HEPLISAV B (Hepatitis B

RHEA-AI

very positive